SARS-CoV-2 3CL pro inhib Products


Phase N/A 1 2 3 4 Trials	0	112233445566778899110



Paxlovid (nirmatrelvir/ritonavir) / Pfizer




Kinaction (masitinib) / AB Science




Xiannuoxin (simnotrelvir) / Simcere, Shanghai Inst. of Materia Medica




leritrelvir (RAY1216) / Guangdong Zhongsheng Pharma




GST-HG171 / Fujian Cosunter




Xocova (ensitrelvir) / Shionogi




Ovydso (olgotrelvir) / Sorrento




bofutrelvir (FB2001) / Frontier Biotech




ibuzatrelvir (PF-07817883) / Pfizer




lufotrelvir (PF-07304814) / Pfizer




EDP-235 / Enanta Pharma




QLS1128 / Qilu Pharma




pomotrelvir (PBI-0451) / Pardes Biosci




ASC11 / Ascletis




Pentarlandir (SNB011) / SyneuRx




Tollovir (NLC-V-01) / Todos Medical



	Diseases Companies Products Productz Mechanisms of Action Sites